Literature DB >> 16713996

Over-expression of Kv1.5 in rat cardiomyocytes extremely shortens the duration of the action potential and causes rapid excitation.

Yasutaka Tanabe1, Katsuharu Hatada, Naoki Naito, Yoshiyasu Aizawa, Masaomi Chinushi, Hiroyuki Nawa, Yoshifusa Aizawa.   

Abstract

BACKGROUND: Genetically abnormal action potential duration (APD) can be a cause of arrhythmias that include long and short QT interval syndrome.
PURPOSE: The aim of this study was to evaluate the arrhythmogenic effect of short QT syndrome induced by the over-expression of Kv1.5 in rat.
METHODS: From Sprague-Dawley rats on fetal days 18-19, cardiomyocytes were excised and cultured with and without transfection with the Kv-1.5 gene using an adenovirus vector. The expression of Kv1.5 was proven by immunohistochemistry and Western blot analysis. In the culture dish and in the whole cells, the electrical activities were recorded using the whole-cell patch-clamp technique and the effects of 4-AP and verapamil were tested.
RESULTS: After transfection with Kv1.5 for 12h, immunohistochemical staining and Western blot analysis were positive for Kv1.5 while they were negative in the control transfected with only Lac-Z. In the culture dish, the myocytes showed spontaneous beating at 115beats/min (bpm) just prior to the transfection with Kv1.5 and increased to 367bpm at 24h. The control myocytes showed stable beating rates during culturing. 4-AP at 200microM slowed down the rate and verapamil abolished the beating. In the whole cells, the maximal resting membrane potential was slightly depolarized and APD was extremely abbreviated both at 50% and 90% of repolarization compared with those of the control. Rapid spontaneous activities were found in a single myocyte with Kv1.5 transfection and 4-AP slowed down the frequency of the activities with a reversal of the shortened APD.
CONCLUSION: The over-expression of Kv1.5 induced short APD and triggered activities in rat cardiomyocytes. This model can be used to study the arrhythmogenic substrate of short QT syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713996     DOI: 10.1016/j.bbrc.2006.05.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

2.  Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.

Authors:  Sarah M Schumacher-Bass; Eileen D Vesely; Lian Zhang; Katherine E Ryland; Dyke P McEwen; Priscilla J Chan; Chad R Frasier; Jeremy C McIntyre; Robin M Shaw; Jeffrey R Martens
Journal:  Circ Res       Date:  2014-02-07       Impact factor: 17.367

3.  Expression of KCNA5 Protein in Human Mammary Epithelial Cell Line Associated with Caveolin-1.

Authors:  Jia Liu; Chao Qu; Hongyan Li; Yejun Zhang; Jia Sun; Shuo Yang; Jing Liu; Lijia An; Wei Zou
Journal:  J Membr Biol       Date:  2016-04-13       Impact factor: 1.843

4.  Inhalation of printer-emitted particles impairs cardiac conduction, hemodynamics, and autonomic regulation and induces arrhythmia and electrical remodeling in rats.

Authors:  Alex P Carll; Renata Salatini; Sandra V Pirela; Yun Wang; Zhengzhi Xie; Pawel Lorkiewicz; Nazratan Naeem; Yong Qian; Vincent Castranova; John J Godleski; Philip Demokritou
Journal:  Part Fibre Toxicol       Date:  2020-01-29       Impact factor: 9.400

5.  Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors.

Authors:  Lingyue Zhao; Qian Yang; Yiqun Tang; Qidong You; Xiaoke Guo
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.